MARÍA DOLORES
CABALLERO BARRIGÓN
Ikertzailea 1998-2022 tartean
Essen University Hospital
Essen, AlemaniaEssen University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2023
2022
2021
-
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491
2019
-
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
The Lancet, Vol. 393, Núm. 10168, pp. 229-240
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2004
-
Lenograstim after autologous peripheral blood progenitor cell transplantation: Results of a double-blind, randomized trial
Bone Marrow Transplantation, Vol. 34, Núm. 11, pp. 955-962
2003
2002
-
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia
Blood, Vol. 100, Núm. 12, pp. 3877-3886